These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 8178901)

  • 21. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women.
    Petersen KR; Sidelmann J; Skouby SO; Jespersen J
    Am J Obstet Gynecol; 1993 Jan; 168(1 Pt 1):32-8. PubMed ID: 8420344
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Potential advantages of triphasic combined oral contraceptives in the light of recent epidemiological and endocrinometabolic data].
    Gaspard U; Dubois M
    Contracept Fertil Sex (Paris); 1982 Sep; 10(9):551-60. PubMed ID: 12311606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of oral contraceptives on blood coagulation. A review.
    Beller FK; Ebert C
    Obstet Gynecol Surv; 1985 Jul; 40(7):425-36. PubMed ID: 3895067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
    Cachrimanidou AC; Hellberg D; Nilsson S; von Schoulz B; Crona N; Siegbahn A
    Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptives, clotting factors, and thrombosis.
    Meade TW
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):758-61. PubMed ID: 6801980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bias versus causality: interpreting recent evidence of oral contraceptive studies.
    Spitzer WO
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S43-50. PubMed ID: 9753310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescription contraceptives: countering the risks.
    Ruggiero RJ
    Am Pharm; 1985 Sep; NS25(9):32-7. PubMed ID: 4050670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis.
    Alving BM; Comp PC
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1184-91. PubMed ID: 1415444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral contraception and coagulation.
    Notelovitz M
    Clin Obstet Gynecol; 1985 Mar; 28(1):73-83. PubMed ID: 3987135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral contraception and surgery].
    Houssel P; Gouezec H; Malledant Y; Nolain E; Le Bouquin V; Orain C; Saint-Marc C
    Cah Anesthesiol; 1989 Oct; 37(6):451-4. PubMed ID: 2691023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative status and oral contraceptive. Its relevance to platelet abnormalities and cardiovascular risk.
    Ciavatti M; Renaud S
    Free Radic Biol Med; 1991; 10(5):325-38. PubMed ID: 1855673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modern oral contraceptives and cardiovascular disease.
    Rosenberg L; Palmer JR; Sands MI; Grimes D; Bergman U; Daling J; Mills A
    Am J Obstet Gynecol; 1997 Sep; 177(3):707-15. PubMed ID: 9322646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
    Spona J; Feichtinger W; Kindermann C; Schneider B; Mellinger U; Walter F; Moore C; Gräser T
    Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in the plasma levels of proteins C and S in young women on low-dose oestrogen oral contraceptives.
    Granata A; Sobbrio GA; D'Arrigo F; Barillari M; De Luca P; Egitto M; Granese D; Pullè C; Trimarchi F
    Clin Exp Obstet Gynecol; 1991; 18(1):9-12. PubMed ID: 1829030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined contraceptives and cardiovascular risk].
    Belaisch J; Hommais-loufrani B
    Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on oral contraception.
    Rabe T; Runnebaum B
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):10-2. PubMed ID: 8365502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.